Paper34278663
Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis.
Kowada A and 1 other. Helicobacter, 2021. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis. Papers, record 34278663. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34278663
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Helicobacter Infections | Major topic |
| Helicobacter pylori | Major topic |
| Stomach Neoplasms | Major topic |
| Aged | |
| Cost-Benefit Analysis | |
| Humans | |
| Japan | |
| Middle Aged | |
| Policy |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| No funding was received for this study. | PubMed |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27342689 | Japanese gastric cancer treatment guidelines 2014 (ver. 4). | Gastric Cancer | 2017 | https://conductscience.org/library/papers/27342689 | PubMed |
| 2 | 31111585 | Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition. | Helicobacter | 2019 | https://conductscience.org/library/papers/31111585 | PubMed |
| 3 | 33004546 | Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. | Gut | 2020 | https://conductscience.org/library/papers/33004546 | PubMed |
| 4 | 31559966 | Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial. | Lancet Infect Dis | 2019 | https://conductscience.org/library/papers/31559966 | PubMed |
| 5 | 33519193 | Cost‑effectiveness Analysis of Helicobacter pylori Eradication Therapy in First-Degree Relatives of Patients with Gastric Cancer. | Patient Prefer Adherence | 2021 | https://conductscience.org/library/papers/33519193 | PubMed |
| 6 | 24833876 | Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/24833876 | PubMed |
| 7 | 31320930 | Current status of first- and second-line Helicobacter pylori eradication therapy in the metropolitan area: a multicenter study with a large number of patients. | Ther Adv Gastroenterol | 2019 | https://conductscience.org/library/papers/31320930 | PubMed |
| 8 | 25162885 | Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold. | N Engl J Med | 2014 | https://conductscience.org/library/papers/25162885 | PubMed |
| 9 | 31190581 | Cost-effectiveness of Helicobacter pylori test and eradication versus upper gastrointestinal series versus endoscopy for gastric cancer mortality and outcomes in high prevalence countries. | Scand J Gastroenterol | 2019 | https://conductscience.org/library/papers/31190581 | PubMed |
| 10 | 32523315 | Clinicopathological features of early gastric cancers arising in Helicobacter pylori uninfected patients. | World J Gastroenterol | 2020 | https://conductscience.org/library/papers/32523315 | PubMed |
| 11 | 31673902 | Cost-Effectiveness Analysis of Helicobacter pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model. | Dig Dis Sci | 2020 | https://conductscience.org/library/papers/31673902 | PubMed |
| 12 | 32285569 | Helicobacter pylori "Test-and-Treat" strategy with urea breath test: A cost-effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain-Results of the Hp-Breath initiative. | Helicobacter | 2020 | https://conductscience.org/library/papers/32285569 | PubMed |
| 13 | 26198377 | Helicobacter pylori eradication for the prevention of gastric neoplasia. | Cochrane Database Syst Rev | 2015 | https://conductscience.org/library/papers/26198377 | PubMed |
| 14 | 24162382 | Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan. | J Gastroenterol | 2014 | https://conductscience.org/library/papers/24162382 | PubMed |
| 15 | 31857433 | Effect of Helicobacter pylori on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer. | Gut | 2020 | https://conductscience.org/library/papers/31857433 | PubMed |
| 16 | 28771894 | Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan. | Helicobacter | 2017 | https://conductscience.org/library/papers/28771894 | PubMed |
| 17 | 32792335 | Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands. | Gut | 2021 | https://conductscience.org/library/papers/32792335 | PubMed |
| 18 | 29872276 | Estimation of population-based utility weights for gastric cancer-related health states. | Patient Prefer Adherence | 2018 | https://conductscience.org/library/papers/29872276 | PubMed |
| 19 | 24914352 | Histological changes of gastric mucosa after Helicobacter pylori eradication: a systematic review and meta-analysis. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/24914352 | PubMed |
| 20 | 27623463 | Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine. | JAMA | 2016 | https://conductscience.org/library/papers/27623463 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42283782 | Helicobacter pylori eradication in the face of escalating anti-microbial resistance: Geographic heterogeneity and emerging treatment strategies. | Indian J Gastroenterol | 2026 | https://conductscience.org/library/papers/42283782 | PubMed |
| 42178557 | Early population-level impact of Helicobacter pylori eradication on gastric cancer mortality in Japan: a counterfactual analysis of short-term divergence. | Popul Health Metr | 2026 | https://conductscience.org/library/papers/42178557 | PubMed |
| 41830305 | Usefulness of Molecular Diagnostic Kits for Detecting Helicobacter pylori Infection in Patients Receiving Proton Pump Inhibitors and Potassium-Competitive Acid Blockers. | Biomed Res Int | 2026 | https://conductscience.org/library/papers/41830305 | PubMed |
| 40550534 | Experts' Perceptions Regarding Testing for Helicobacter pylori Infection During Upper Gastrointestinal Endoscopy and Subsequent Eradication Therapy. | Korean J Helicobacter Up Gastrointest Res | 2025 | https://conductscience.org/library/papers/40550534 | PubMed |
| 40433232 | Current Status of Gastric Cancer Screening and Future Perspectives. | DEN Open | 2026 | https://conductscience.org/library/papers/40433232 | PubMed |
| 40131569 | Economic Evaluation of Gastric Cancer Screening Strategies: A Systematic Review. | J Gastrointest Cancer | 2025 | https://conductscience.org/library/papers/40131569 | PubMed |
| 40059928 | Cost-effectiveness of adding a Helicobacter pylori antibody test to the upper gastrointestinal series in gastric cancer screening at the workplace. | Environ Occup Health Pract | 2023 | https://conductscience.org/library/papers/40059928 | PubMed |
| 39735441 | Helicobacter pylori eradication for primary prevention of gastric cancer: progresses and challenges. | J Natl Cancer Cent | 2024 | https://conductscience.org/library/papers/39735441 | PubMed |
| 39684537 | The Aging Stomach: Clinical Implications of H. pylori Infection in Older Adults-Challenges and Strategies for Improved Management. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39684537 | PubMed |
| 38204445 | Health economic evaluation on population-based Helicobacter pylori eradication and endoscopic screening for gastric cancer prevention. | Chin J Cancer Res | 2023 | https://conductscience.org/library/papers/38204445 | PubMed |
| 38006568 | Randomized controlled trial comparing the costs of gastric cancer screening systems between serological risk-based upper gastrointestinal endoscopy and the existing barium photofluorography: gastric cancer screening labeled by serum examination in place of aged gastric cancer organized screening systems (GALAPAGOS study). | Gastric Cancer | 2024 | https://conductscience.org/library/papers/38006568 | PubMed |
| 37680407 | Unpacking the Racial Gap: Helicobacter pylori Infection Clearance Among Different Racial Groups. | Cureus | 2023 | https://conductscience.org/library/papers/37680407 | PubMed |
| 36565366 | A Population-Based Helicobacter pylori Eradication Strategy Is More Cost-Effective than Endoscopic Screening. | Dig Dis Sci | 2023 | https://conductscience.org/library/papers/36565366 | PubMed |
| 36538198 | The cure rate of 10-day bismuth-containing quadruple therapy for Helicobacter pylori eradication is equivalent to 14-day: a systematic review and meta-analysis. | Clin Exp Med | 2023 | https://conductscience.org/library/papers/36538198 | PubMed |
| 36317116 | Helicobacter Pylori Infection Induces Intestinal Dysbiosis That Could Be Related to the Onset of Atherosclerosis. | Biomed Res Int | 2022 | https://conductscience.org/library/papers/36317116 | PubMed |
| 36204804 | Practice guidelines for the management of Helicobacter pylori infection: The Saudi H. pylori Working Group recommendations. | Saudi J Gastroenterol | 2023 | https://conductscience.org/library/papers/36204804 | PubMed |
| 35343031 | Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost-effectiveness analysis. | Helicobacter | 2022 | https://conductscience.org/library/papers/35343031 | PubMed |
| 35078854 | What is the general Chinese public's awareness of and attitudes towards Helicobacter pylori screening and associated health behaviours? A cross-sectional study. | BMJ Open | 2022 | https://conductscience.org/library/papers/35078854 | PubMed |
| 34660627 | Helicobacter pylori Infection in Geriatric Patients: Current Situation and Treatment Regimens. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34660627 | PubMed |
| 34278663 | Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis. | Helicobacter | 2021 | https://conductscience.org/library/papers/34278663 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34278663
GET https://conductscience.org/api/papers/v1/34278663/references?page=2